| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0084 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |